AGP Executive Report

Noninvasive Brain Stimulation: A new trial reports overlapping electrical currents on the scalp can ease Parkinson’s motor symptoms for at least an hour after one session, offering a less invasive alternative to deep brain stimulation. Research Funding Fight: Scientists and universities are pushing back hard on proposed U.S. grant-rule changes that would expand political appointees’ control over research awards, warning it could destabilize the federal science pipeline. Public Health Vaccines: A pregnancy RSV vaccine (RSVpreF) cut infant RSV-related hospitalization risk by about 70%, strengthening the case for maternal immunization. Diabetes Tech in Clinics: Two ADA studies point to scalable early type 1 diabetes screening, including a fully remote genetics-first model using at-home saliva. Climate & Disasters: India’s monsoon outlook for the Hindu Kush Himalaya region warns that even a weaker monsoon won’t remove flash-flood and landslide risk, as intense bursts and heat can swing between drought and deluge. Agriculture Data: Minnesota expanded its Ag Weather Network with new stations to give farmers more localized, real-time weather and soil data for better field decisions. AI for Science: Microsoft’s Discovery Platform moves agentic AI into general availability for research workflows, aiming to connect data and knowledge so agents can support hypothesis and experimentation.

Solid-State Batteries: Dongfeng says it will mass-produce and install its next-gen solid-state batteries in vehicles in the second half of 2026, using an automated pilot line and design tweaks to cut thermal runaway risk. Nuclear Oversight: The IAEA has started a visit to Bangladesh’s Rooppur plant as it moves into the operational phase, with on-site inspections and safety checks. Timekeeping Breakthrough: Scientists unveiled the first working nuclear clock, using atomic nuclei vibrations for ultra-precise time measurement. Climate Shock: NOAA confirmed El Niño is forming and could reach historic strength, raising odds of extreme heat, floods, droughts, and wildfires. Public Health & AMR: A study argues antimicrobial resistance is driven heavily by inequality and living conditions, so antibiotic cuts alone won’t solve it. AI in Commerce: Flipkart hired senior leaders for AI/data science and fintech/payments engineering to push its digital commerce and financial services. Space & Industry: Rocket Lab was added to the Nasdaq-100, while Japan’s H3 rocket successfully launched on a domestic mission. STEM Education: Camp Invention at the Ruth Patrick Science Education Center ran hands-on STEM classes for K–6 students.

Medical Tech: Vanderbilt researchers report that a mobile intraoperative PET-CT can map scattered residual head-and-neck tumors after chemoimmunotherapy, aiming to sharpen margin decisions. Neuroimmune Biotech: ChronicleBio names immunology veteran John Mumm as CSO to push multi-omics/AI drug discovery for ME/CFS, Long COVID, and POTS. Immunology/Oncology Leadership: Harbour BioMed appoints Luisa Salter-Cid as Scientific Advisor; Viking Therapeutics brings in Hubert Chen as Chief Medical Officer. Public Health & Policy: Rhode Island confirms a new Cannabis Control Commission chair, while the U.S. intelligence nomination of Jay Clayton spotlights shifting oversight priorities. Climate & Risk: NOAA says El Niño is forming and could hit historic strength, raising odds of extreme heat, floods, droughts, and fires. Health & Lifestyle: A large study backs combining aerobic exercise with resistance training for lower mortality risk. Veterinary Innovation: Pelara launches first U.S. veterinary clinical trials of low-intensity focused ultrasound for chronic pain. Business/Techbio Finance: UniUni files for a Canadian public listing as it scales last-mile delivery.

Medical animation for pharma: Prolific Studio says it has delivered 100+ healthcare animation projects since launching its medical division in 2020, spanning FDA support and patient education. Life-science policy & industry: Canada’s Industry Minister Mélanie Joly will join Apotex for a TMX bell-ringing event highlighting the life sciences sector. Genetic medicine progress: Eyam Health graduated from Creative Destruction Lab’s Vancouver Biomedical stream after nine months, reporting large-animal proof for its Gemini platform and stronger pharma partnerships as it moves toward IND-enabling work. Skincare commercialization: Zytrell Skin Solutions plans 2026 expansion (cleanser and moisturizer) after launching a 2% salicylic acid acne treatment cream, aiming for retail and digital growth. Battery recycling breakthrough: Cornell researchers propose DEER, a direct electrode-to-electrode regeneration method that restores spent EV battery electrodes to near-original performance with lower cost. Science funding shock: The NSF has begun dismantling the Ocean Observatories Initiative early, raising alarms about lost ocean-climate monitoring. AI model governance: Anthropic withdrew hidden Claude Fable 5 restrictions after backlash, reigniting debate over who gets access to advanced AI capabilities. Deep-sea mining rules: Experts warn U.S. “bare bones” laws may be unfit to regulate nascent deep-sea mining. Health & tech careers: India sees cognitive science as a fast-growing field bridging AI and human behavior, with roles spanning AI ethics and human-AI interaction.

AI in Education: UAE’s higher-education leaders and tech partners met to map how AI can reshape university models and workforce-ready skills. Supply-Chain Tech Funding: Australia awarded $4m in traceability grants to digitize farm-to-market data and speed biosecurity and food-safety responses. Health Tech & Policy: The U.S. medical-cannabis reclassification (Schedule III) could unlock federal tax benefits, while broader rules remain fragmented. Cybersecurity AI Access: Anthropic launched Claude Mythos 5 for trusted organizations and a safer public Claude Fable 5, aiming to curb misuse. Deep-Sea Discovery: Scientists found the Indian Ocean’s massive, ancient whale graveyard ecosystem, with life thriving up to 23,000 feet down. Manufacturing Acceleration: DOE and Argonne launched a “National Science-at-Scale Collaborative” to move critical-materials and chemical manufacturing from lab to pilot scale faster. Medical Breakthroughs: Oxford-led work links inflammatory bowel disease to distinct immune mechanisms involving IL-10, enabling more targeted approaches. AI for Oncology Diagnostics: A new deep-learning system predicts brain-tumor molecular subtypes in minutes from standard tissue slides, bypassing slower methylation testing. Climate & Water Stress: A global study says freshwater extremes are now about twice as common as pre-industrial baselines.

Gene Therapy Breakthrough: Israeli researchers report the first experimental gene therapy injected directly into a child’s brain neurons to treat a rare epilepsy disorder, a major step for neurogenetics. AI + Accelerated Computing: AMD and Imperial team up to apply AI-enabled HPC to problems spanning materials, climate modeling, neuroscience, genomics and biosecurity, aiming for more “sovereign” AI infrastructure. Obesity Drug Pipeline: Biomed Industries advances NA-931 into global Phase 3, testing it alone and alongside oral semaglutide for long-term weight maintenance after GLP-1 discontinuation. Healthcare Connectivity: Lantronix and Cherry & White launch a rapid Wi‑Fi platform for critical infrastructure, targeting secure, deployable connectivity in minutes. Battery Manufacturing Push: EQONIC wins the UK’s £452m Battery Innovation Programme, backing digital-twin-driven production for next-gen energy storage. STEM Workforce Building: UAE’s EGA expands STEM labs in schools and universities to train future engineers using industry-style equipment. Public Health + Policy: Prince William’s Homelessness Data Lab will use business-style analytics to spot people at risk earlier, with partners including Salesforce and LandAid. Science in Conflict Zones: Iran’s Laser and Plasma Institute resumes research days after attacks, highlighting how photonics work continues despite damage.

Diabetes Breakthrough: CagriSema (cagrilintide + semaglutide) cut HbA1c and body weight across REIMAGINE phase 3 trials, pointing to a next-gen combo for type 2 diabetes. Opioid-Use Disorder Research: NIH began the first randomized, placebo-controlled Phase I trial of purified mitragynine (MG001) for opioid use disorder, moving kratom science into FDA-regulated testing. Public Health Tech: With vaccine trust slipping, Penn Engineering says AI chatbots can match traditional materials in tackling vaccine hesitancy, based on JAMA Network Open findings. AI Safety & Reliability: A new push argues AI must be treated as fallible in high-stakes work, stressing human verification and limits of confident outputs. Space & Biomanufacturing: NASA named the Artemis III crew, while UC San Diego explored using plants to produce plant-virus-based pharmaceuticals under space-like conditions. Industry & Infrastructure: Ingredion agreed to buy Tate & Lyle for about $5B, and Hubbell completed its NSI Industries acquisition to expand electrical components. STEM & Skills: Bulgaria’s dual education forum highlighted shortages in engineering and tech roles, while Southern Arkansas University launched a B.S. in Emergency Management for Fall 2026.

Biotech & Pharma Deals: GSK is buying Nuvalent for $10.6B to expand its targeted lung cancer pipeline, a major oncology bet for its new CEO. Clinical Innovation: Life Biosciences dosed the first patient in its Phase 1 ER‑100 epigenetic restoration trial for optic neuropathies, while Treos Bio shared long-term MSS metastatic colorectal cancer results tied to its PEPI platform. Public Health & Vaccines: UMD researchers reported early trial safety for a dual Lassa fever/rabies vaccine, and new Ebola vaccine work continues to push toward broader protection. Medical Tech Markets: Reports project smart medical devices hitting $132.1B by 2031 and medical device affairs outsourcing reaching $8.1B by 2031, reflecting growing regulatory and connected-care demand. Preclinical Testing Shift: ADME toxicology testing is forecast to nearly double to $17.48B by 2035 as regulators lean on in vitro and in silico methods. AI in Biomed: A collaboration aims to build an AI-enabled multi-omics platform for NF1 patient stratification and biomarker discovery. Tech & Industry: KBR won a $95M digital engineering contract for the US Space Force, and Helionis Labs raised pre-seed funding to tackle thermal management for high-power electronics.

AI Energy Breakthrough: UMass Amherst researchers unveiled a brain-inspired AI framework aimed at cutting energy use while keeping performance, pushing toward more scalable, embedded AI. Behavioral Health: A large wearable-based study finds a fast, bidirectional loop between light movement and mood boosts, while an ED “nudge” approach increases naltrexone prescriptions for alcohol use disorder. Precision Medicine & Biotech: A disease-focused vision-language AI model targets kidney cancer, and Sniffles2 improves structural variant detection from long-read sequencing. Public Health & Pharma: Phase 3 data support once-weekly oral HIV therapy, and survodutide trials report major visceral and liver fat reductions. Medical Research: New work links hyperoxia to bronchopulmonary dysplasia mechanisms, and studies explore exercise’s effects on older adults’ executive function. Biosecurity: USDA confirmed additional New World screwworm cases, including one in New Mexico, as containment efforts continue.

AI Infrastructure & Power Demand: Texas’ grid operator ERCOT says data-center connection requests have surged, with developers eyeing massive new loads for AI compute—raising reliability and planning pressure. Semiconductors & “AI Factories”: Korea is pushing Nvidia’s GPU and physical-AI rollout, while Nvidia and LG unveil an “AI factory” push for autonomous vehicles and robotics. Research Breakthroughs: Los Alamos researchers say they’ve completed a mathematical framework for how humans perceive colour, and ancient DNA work helped propose an identity for a 300-year-old colonial burial. Biotech & Drug Updates: ADA-focused obesity and diabetes pipeline news continues, including new Phase 3/clinical updates around GLP-1-style therapies and other metabolic candidates. STEM Pathways: Qatar’s MoEHE will let arts-track students bridge into STEM majors, and IIT Mandi adds new BTech options spanning quantum and data analytics. Science Policy & Trust: Coverage highlights renewed pressure on US science funding and editorial independence amid political interference concerns. Education & Community Science: From rocket-building teams to school science lessons and medical screenings, hands-on tech learning keeps showing up worldwide.

Federal Education Policy: Trump’s “One Big Beautiful Bill” tightens federal student loan caps for graduate and professional schools, including a $50,000/year limit for law and medical programs and a $257,000 lifetime cap, with UCLA warning summer loan processing delays. Climate Watch: The UN’s World Meteorological Organization confirms El Niño is back, with Pacific heat running far above average and fears of a “super El Niño” driving extreme weather. Medical Breakthroughs: Extended-release febuxostat beats standard for chronic gout urate control; new GLP-1 and related obesity data keep rolling in, including ecnoglutide’s head-to-head weight-loss edge and monthly GLP-1 efforts; a gut-microbe study links indoles to anxiety regulation, pointing to next-gen probiotics. Diabetes Tech: Diasome’s HDV-insulin lispro maintains glycemic control while reducing severe hypoglycemia, and real-world Huntington data suggest deutetrabenazine may improve quality of life. Alzheimer’s Research: Scientists map microglia state transitions that may explain why some people stay cognitively resilient despite Alzheimer’s pathology. Space & Materials: China advances “space power bank” wireless energy tests, while Argonne researchers tailor MXenes at near-atomic precision for future electronics. Health & Safety: Australia’s top neurologists accuse the regulator of ignoring concerns over paraquat’s Parkinson’s risk. Science in the Wild: A Brazilian expedition confirms 2+ dozen new marine species in days using shipboard imaging and sequencing.

Universal vaccine breakthrough: Cambridge and DIOSynVax say an AI-designed “super-antigen” coronavirus vaccine cleared its first human trial in 39 volunteers, aiming for broad protection across sarbecoviruses and future mutations. Public health tech: The ADA’s 2026 Innovation Challenge named Adaptyx Biosciences, Nymble Health, and Silverstream Medical for wearable and AI-driven diabetes care tools. Medical devices: Researchers report an ultrasound-based “pacemaker” concept using sonogenetics to noninvasively steady heart activity. Healthcare policy & regulation: Nova Scotia moves to regulate naturopathic doctors, while the EU unveils a roadmap to phase out animal testing in chemical safety reviews. AI in education and jobs: Bangladesh pushes mandatory internships and stronger industry-academia links to cut graduate unemployment. STEM capacity building: Ghana’s flagship Abomosu STEM school faces growing pains—staffing, funding, maintenance, and industry partnerships. Environment & health risks: A new $3.3M study will test whether microplastics accumulate in the body and harm the cardiovascular system. Energy and industry: India accelerates coal gasification as a bridge fuel amid LNG shortages, despite higher emissions trade-offs. Space strategy: The Philippines backs new satellite programs to boost sovereign Earth observation and secure geostationary communications.

DNA & Forensics: New York’s annual Missing Persons Day, run by the OCME, brings families to forensic biologists to push cold-case identifications using DNA—an effort the city says has already produced 100+ matches. Public Health Threat: Texas officials and the USDA are racing to respond to the New World screwworm fly after fresh detections, with a sterile-fly facility delayed beyond a year. Biotech Breakthroughs: Researchers report the first highly precise DNA editing in human embryos, reigniting germline debate; separately, a portable CRISPR test is highlighted for Mpox detection in the field. Regenerative Medicine: The University of Miami opens a 3D bioprinting lab aimed at living tissue, bone, and faster wound-healing approaches. AI + Industry: Intel’s AI bootcamp trains students for real-world projects, while reports say Bitcoin miners are pivoting into AI data centers. Climate Science: New work uses lake mud records to refine how soot darkened Arctic snow and sped melting.

AI Safety Debate: Anthropic co-founder Jack Clark says the AI industry is accelerating “without a brake pedal,” warning that self-improving systems could outpace human oversight. Ocean Forecasting: China’s CAS unveiled LangYa 2.0, an upgraded ocean forecasting AI aimed at predicting typhoons, storm surges, and other complex marine events for disaster planning and shipping. Biotech for Food Security: Nigeria’s experts urged urgent investment in biotechnology to strengthen food security, healthcare resilience, and jobs, highlighting a national push to turn bioresources into innovation. Traditional Medicine R&D: China and Pakistan launched a Zhejiang-Pakistan joint herbal medicine lab, building a formal research pipeline across universities and hospitals. Cancer Diagnostics: India reported a blood-based protein signature that may flag lung cancer risk more than five years early, positioning it as a risk tool for earlier monitoring. Education & Skills: Russia’s TMK at SPIEF backed faster university-industry collaboration through legal and institutional support, while India’s KCET results confirmed engineering eligibility for admissions at scale. Public Health Misinformation: Canada’s medical journal update reassures that acetaminophen (Tylenol) is safe in pregnancy when used as directed, countering earlier unsupported warnings. Medical Tech Innovation: Researchers described a portable point-of-care PET system designed to bring real-time molecular imaging to interventional radiology.

Biotech Breakthrough: Utah State University researchers say a new CRISPR tool inspired by cave bacteria (Cas12a2) can selectively target and shred DNA in cancer cells, pointing to fresh gene-editing cancer strategies. Cancer Drug Mechanism Rethink: Baylor researchers challenge the idea that HDAC inhibitors work only by blocking HDAC enzymes, arguing they may hit other pathways—an important step toward better targeted therapies. Addiction Neurobiology: A Q&A highlights preclinical work on GATC-1021, designed to modulate serotonin receptors to reduce fentanyl intake and boost brain plasticity markers, aiming for new opioid use disorder options. Gene Editing Ethics: Columbia scientists report highly precise base editing in early human embryos, sparking renewed debate over disease repair versus trait selection. AI Safety Debate: Anthropic calls for a global pause on frontier AI development, warning about recursive self-improvement risks and the need for coordinated “brake pedal” safeguards. Energy & Industry: DOE and Japan launch a $1B Genesis Mission research partnership spanning quantum, fusion, biotech, materials, particle physics, and autonomous labs. Nuclear Expansion: Uzbekistan issues a construction license for a nuclear unit using an RITM-200N reactor, with IAEA-aligned safety review. Health Tech & Care: University of Miami opens a $5M 3D bioprinting lab for regenerative medicine, drug development, and patient-specific models. Wildlife & Climate: Studies report endangered Hawaiian false killer whales are losing hundreds of pounds fast, while deep-ocean trenches reveal dense life on bare rock. Policy & Public Health: A JAMA study finds maternal RSV vaccination during pregnancy cuts infant RSV hospitalizations by nearly 70%.

AI in Biomed: Cambridge researchers say an AI-designed “super-antigen” vaccine could target whole virus families, with a human trial already showing safety and a phase II push underway. Space & Defense Tech: MIT engineers tested a small-satellite hybrid propulsion approach that pairs chemical thrust with efficient electric propulsion using the same fuel—aimed at faster Mars-class missions. Climate & Ocean Monitoring: Scientists warn that dismantling a key US ocean observation system would leave the world “flying blind,” degrading storm and El Niño forecasting. Big Science via AI: Japan becomes the first international partner in the US “Genesis Mission,” a government-backed AI science push spanning quantum, fusion, semiconductors, biotech, and materials. Energy Transition: Cambodia’s garment industry could gain from decarbonization pressure, leveraging a relatively clean grid and renewables to attract low-carbon manufacturing investment. Health Policy: Radiologists and other researchers are alarmed by proposed US federal grant rule changes that could add compliance burdens and politicize funding decisions. Agritech & Food Systems: China identified a high-protein gene in wild corn to boost feed protein and reduce reliance on imports. Environment & Health: A new study-backed myth-buster says there’s no need to wait 30 minutes after eating before swimming.